Utilization and Effectiveness of the CA 19-9 Test for Cancer Diagnosis: Insights from Health Ministry Records
Introduction:This retrospective study evaluated the use and findings of the CA 19-9 test in the diagnosis of pancreatic cancer.Methods:The study analyzed data from a large population of 2,981,142 individuals who underwent CA 19-9 testing between 2017 and 2021. The number of tests performed, test rat...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2023-08-01
|
| Series: | İstanbul Medical Journal |
| Subjects: | |
| Online Access: |
http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/utilization-and-effectiveness-of-the-ca-19-9-test-/61907
|
| _version_ | 1827854686075486208 |
|---|---|
| author | Mustafa Mahir Ülgü Şuayip Birinci |
| author_facet | Mustafa Mahir Ülgü Şuayip Birinci |
| author_sort | Mustafa Mahir Ülgü |
| collection | DOAJ |
| description | Introduction:This retrospective study evaluated the use and findings of the CA 19-9 test in the diagnosis of pancreatic cancer.Methods:The study analyzed data from a large population of 2,981,142 individuals who underwent CA 19-9 testing between 2017 and 2021. The number of tests performed, test rates per 100,000 population, and 25,808,137 test results were assessed. The study also investigated the association between CA 19-9 levels and cancer diagnoses.Results:The study found that CA 19-9 was a widely used tumor marker for pancreatic cancer diagnosis. However, it was noted that the test had limitations as a standalone diagnostic tool. In the analyzed population, the test results showed elevated CA 19-9 levels in more than 80% of patients diagnosed with pancreatic cancer. The study also observed variations in test use and outcomes across different age groups, genders and regions.Conclusion:Our findings highlight the significance of the CA 19-9 test in the diagnosis of pancreatic cancer. However, it is crucial to consider the limitations of using CA 19-9 as a standalone test and incorporate it into a comprehensive diagnostic approach involving other clinical and laboratory methods. Further multicenter and prospective studies are warranted to better understand the accuracy and effectiveness of the CA 19-9 test in pancreatic cancer diagnosis. |
| first_indexed | 2024-03-12T11:26:17Z |
| format | Article |
| id | doaj.art-990baf93155f4dc0b7c22e96cf8f1777 |
| institution | Directory Open Access Journal |
| issn | 2619-9793 2148-094X |
| language | English |
| last_indexed | 2024-03-12T11:26:17Z |
| publishDate | 2023-08-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | İstanbul Medical Journal |
| spelling | doaj.art-990baf93155f4dc0b7c22e96cf8f17772023-09-01T08:44:19ZengGalenos Yayineviİstanbul Medical Journal2619-97932148-094X2023-08-0124332232710.4274/imj.galenos.2023.7542813049054Utilization and Effectiveness of the CA 19-9 Test for Cancer Diagnosis: Insights from Health Ministry RecordsMustafa Mahir Ülgü0Şuayip Birinci Acting Director - General at Ministry of Health of Turkey Introduction:This retrospective study evaluated the use and findings of the CA 19-9 test in the diagnosis of pancreatic cancer.Methods:The study analyzed data from a large population of 2,981,142 individuals who underwent CA 19-9 testing between 2017 and 2021. The number of tests performed, test rates per 100,000 population, and 25,808,137 test results were assessed. The study also investigated the association between CA 19-9 levels and cancer diagnoses.Results:The study found that CA 19-9 was a widely used tumor marker for pancreatic cancer diagnosis. However, it was noted that the test had limitations as a standalone diagnostic tool. In the analyzed population, the test results showed elevated CA 19-9 levels in more than 80% of patients diagnosed with pancreatic cancer. The study also observed variations in test use and outcomes across different age groups, genders and regions.Conclusion:Our findings highlight the significance of the CA 19-9 test in the diagnosis of pancreatic cancer. However, it is crucial to consider the limitations of using CA 19-9 as a standalone test and incorporate it into a comprehensive diagnostic approach involving other clinical and laboratory methods. Further multicenter and prospective studies are warranted to better understand the accuracy and effectiveness of the CA 19-9 test in pancreatic cancer diagnosis. http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/utilization-and-effectiveness-of-the-ca-19-9-test-/61907 ca 19-9pancreatic cancertumor markerdiagnosis |
| spellingShingle | Mustafa Mahir Ülgü Şuayip Birinci Utilization and Effectiveness of the CA 19-9 Test for Cancer Diagnosis: Insights from Health Ministry Records İstanbul Medical Journal ca 19-9 pancreatic cancer tumor marker diagnosis |
| title | Utilization and Effectiveness of the CA 19-9 Test for Cancer Diagnosis: Insights from Health Ministry Records |
| title_full | Utilization and Effectiveness of the CA 19-9 Test for Cancer Diagnosis: Insights from Health Ministry Records |
| title_fullStr | Utilization and Effectiveness of the CA 19-9 Test for Cancer Diagnosis: Insights from Health Ministry Records |
| title_full_unstemmed | Utilization and Effectiveness of the CA 19-9 Test for Cancer Diagnosis: Insights from Health Ministry Records |
| title_short | Utilization and Effectiveness of the CA 19-9 Test for Cancer Diagnosis: Insights from Health Ministry Records |
| title_sort | utilization and effectiveness of the ca 19 9 test for cancer diagnosis insights from health ministry records |
| topic | ca 19-9 pancreatic cancer tumor marker diagnosis |
| url |
http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/utilization-and-effectiveness-of-the-ca-19-9-test-/61907
|
| work_keys_str_mv | AT mustafamahirulgu utilizationandeffectivenessoftheca199testforcancerdiagnosisinsightsfromhealthministryrecords AT suayipbirinci utilizationandeffectivenessoftheca199testforcancerdiagnosisinsightsfromhealthministryrecords |